Effect of a late evening snack of amazake in patients with liver cirrhosis

Effect of a late evening snack of amazake in patients with liver cirrhosis - A late evening snack of patients with liver cirrhosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010550

Enrollment

Registered

2013-04-20

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Each patient used a measuring cup and drank 150 mL of amazake (equivalent to 200 kcal) at bedtime, every night for 12 weeks. The study period comprised 12 weeks with evaluations at baseline (visit 1),

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Liver cirrhosis with sufficient food intake and a serum albumin concentration below 4.0 g/dL

Exclusion criteria

Exclusion criteria: 1. Diabetes mellitus on medication for anti-diabetic drugs 2. Ongoing, self motivated consumption of late evening snacks 3. Hepatic encephalopathy, ascites, hepatocellular carcinoma (HCC) 4. Renal failure 5. Ongoing interferon therapy

Design outcomes

Primary

Measure	Time frame
Quality of life (QOL)	—

Countries

Japan

Contacts

Public ContactYumiko Nagao

Kurume University School of Medicine Department of Digestive Disease Information & Research

nagao@med.kurume-u.ac.jp0942-35-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026